160 related articles for article (PubMed ID: 17472611)
1. Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.
Falkensammer B; Pilz G; Bektić J; Imwidthaya P; Jöhrer K; Speth C; Lass-Flörl C; Dierich MP; Würzner R
Mycoses; 2007 May; 50(3):172-7. PubMed ID: 17472611
[TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.
Bektić J; Lell CP; Fuchs A; Stoiber H; Speth C; Lass-Flörl C; Borg-von Zepelin M; Dierich MP; Würzner R
FEMS Immunol Med Microbiol; 2001 Jul; 31(1):65-71. PubMed ID: 11476984
[TBL] [Abstract][Full Text] [Related]
3. HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces.
Tsang CS; Hong I
Mycoses; 2010 Nov; 53(6):488-94. PubMed ID: 19538521
[TBL] [Abstract][Full Text] [Related]
4. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
5. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.
Borg-von Zepelin M; Meyer I; Thomssen R; Würzner R; Sanglard D; Telenti A; Monod M
J Invest Dermatol; 1999 Nov; 113(5):747-51. PubMed ID: 10571729
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.
Gruber A; Speth C; Lukasser-Vogl E; Zangerle R; Borg-von Zepelin M; Dierich MP; Würzner R
Immunopharmacology; 1999 Apr; 41(3):227-34. PubMed ID: 10428651
[TBL] [Abstract][Full Text] [Related]
7. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
Korting HC; Schaller M; Eder G; Hamm G; Böhmer U; Hube B
Antimicrob Agents Chemother; 1999 Aug; 43(8):2038-42. PubMed ID: 10428932
[TBL] [Abstract][Full Text] [Related]
8. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
Blanco MT; Hurtado C; Pérez-Giraldo C; Morán FJ; González-Velasco C; Gómez-García AC
Med Mycol; 2003 Apr; 41(2):167-70. PubMed ID: 12964850
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
Cassone A; De Bernardis F; Torosantucci A; Tacconelli E; Tumbarello M; Cauda R
J Infect Dis; 1999 Aug; 180(2):448-53. PubMed ID: 10395861
[TBL] [Abstract][Full Text] [Related]
10. Hgc1 mediates dynamic Candida albicans-endothelium adhesion events during circulation.
Wilson D; Hube B
Eukaryot Cell; 2010 Feb; 9(2):278-87. PubMed ID: 20023069
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.
Monod M; Borg-von Zepelin M; Telenti A; Sanglard D
Dermatology; 1999; 198(4):412-4. PubMed ID: 10490300
[No Abstract] [Full Text] [Related]
12. Deletion of ALS5, ALS6 or ALS7 increases adhesion of Candida albicans to human vascular endothelial and buccal epithelial cells.
Zhao X; Oh SH; Hoyer LL
Med Mycol; 2007 Aug; 45(5):429-34. PubMed ID: 17654269
[TBL] [Abstract][Full Text] [Related]
13. Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells.
Armbruster C; Vorbach H; Steindl F; El Menyawi I
J Antimicrob Chemother; 2001 Apr; 47(4):487-90. PubMed ID: 11266428
[TBL] [Abstract][Full Text] [Related]
14. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines.
Ronaldson PT; Lee G; Dallas S; Bendayan R
Pharm Res; 2004 May; 21(5):811-8. PubMed ID: 15180339
[TBL] [Abstract][Full Text] [Related]
15. Failure of indinavir to inhibit Candida albicans in vitro.
Diz Dios P; Otero Varela I; Iglesias Martín I; Ocampo Hermida A; Martínez Vázquez C
Eur J Clin Microbiol Infect Dis; 1999 Oct; 18(10):755-6. PubMed ID: 10584909
[No Abstract] [Full Text] [Related]
16. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
17. Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma.
Pati S; Pelser CB; Dufraine J; Bryant JL; Reitz MS; Weichold FF
Blood; 2002 May; 99(10):3771-9. PubMed ID: 11986235
[TBL] [Abstract][Full Text] [Related]
18. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells.
Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M
Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454
[TBL] [Abstract][Full Text] [Related]
19. Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation.
Hebert VY; Crenshaw BL; Romanoff RL; Ekshyyan VP; Dugas TR
Cardiovasc Toxicol; 2004; 4(2):117-31. PubMed ID: 15371629
[TBL] [Abstract][Full Text] [Related]
20. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
Schaller M; Krnjaic N; Niewerth M; Hamm G; Hube B; Korting HC
J Med Microbiol; 2003 Mar; 52(Pt 3):247-249. PubMed ID: 12621090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
